Engineered Liver Tissue May Replace Transplantation
MIT Tech Review1 min read55 words
A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blood clotting, removing bacteria from the bloodstream, metabolizing drugs,…
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.